Evidence map›Paper›PMID 28239454›Full record

ArticleAntimicrobial resistance and infection control2017

Transcriptional analysis of

Deepjyoti Paul, Amitabha Bhattacharjee, Dibyojyoti Bhattacharjee, Debadatta Dhar, Anand Prakash Maurya, Atanu Chakravarty

Open access · goldAbstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. In vitro activity of the novel β-lactamase inhibitor FL058 combined with meropenem against KPC- or NDM-producing enterobacterales and Pseudomonas aeruginosa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  2. Article
  3. Genetic basis of transmission of blaApplied microbiology and biotechnology · 2025
    Article
  4. First Report in the Americas ofAntibiotics (Basel, Switzerland) · 2025
    Article
  5. Transcriptomic Insights into Adaptive Strategies ofInfection and drug resistance · 2025
    Article
  6. Article
  7. Access microbiology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Deepjyoti PaulDepartment of Microbiology, Assam University, Silchar, India.
Amitabha BhattacharjeeDepartment of Microbiology, Assam University, Silchar, India.
Dibyojyoti BhattacharjeeDepartment of Statistics, Assam University, Silchar, India.
Debadatta DharDepartment of Microbiology, Silchar Medical College and Hospital, Silchar, India.
Anand Prakash MauryaDepartment of Microbiology, Assam University, Silchar, India.
Atanu ChakravartyDepartment of Microbiology, Silchar Medical College and Hospital, Silchar, India.
Assam University · INSilchar Medical College and Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew Delhi metallo beta-lactamase is known to compromise carbapenem therapy and leading to treatment failure. However, their response to carbapenem stress is not clearly known. Here, we have investigated the transcriptional response of

methodsThree

resultsUnder carbapenem stress over an interval of time there was a sharp variation in the transcriptional expression of

conclusionThis study suggests that the single dose of carbapenem pressure does not significantly influence the expression of

Indexed as

Escherichia coliPlasmid stabilityTranscriptional expressionTransferability

Identifiers

PMID28239454
PMCPMC5319162
OpenAlexW2589267268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.